The value of 18FDG-PET for localization of ectopic Cushing's syndrome due to occult bronchial carcinoid

2011 ◽  
Vol 58 (9) ◽  
pp. 497-499
Author(s):  
Alma Prieto-Tenreiro ◽  
José Manuel Cabezas-Agrícola ◽  
Sonia Argibay ◽  
José Manuel Cameselle-Teijeiro ◽  
Felipe Casanueva
Keyword(s):  
Cushing’S Syndrome ◽  
Cushing's Syndrome ◽  
Bronchial Carcinoid ◽  
Ectopic Cushing’S Syndrome ◽  
18Fdg Pet

Plurihormonal bronchial carcinoid associated with ectopic Cushing’s syndrome

1999 ◽  
Vol 10 (4) ◽  
pp. 359-365 ◽  
Author(s):  
Donna Battaglia ◽  
Kalman Kovacs ◽  
Eva Horvath ◽  
Eric Poulin ◽  
Harley S. Smyth
Keyword(s):  
Cushing’S Syndrome ◽  
Cushing's Syndrome ◽  
Bronchial Carcinoid ◽  
Ectopic Cushing’S Syndrome

DETECTION OF AN ACTH-SECRETING BRONCHIAL CARCINOID TUMOUR EIGHTEEN MONTHS AFTER ADRENALECTOMY FOR CUSHING'S SYNDROME

1971 ◽  
Vol 67 (4) ◽  
pp. 625-633 ◽  
Author(s):  
A. C. M. Vingerhoeds ◽  
P. J. der Kinderen ◽  
J. H. H. Thijssen ◽  
F. Schwarz
Keyword(s):  
Differential Diagnosis ◽  
Cushing’S Syndrome ◽  
Carcinoid Tumour ◽  
Cushing's Syndrome ◽  
Bronchial Carcinoid ◽  
Laboratory Methods ◽  
Ectopic Cushing’S Syndrome ◽  
Course Of Action ◽  
Ablative Surgery ◽  
Acth Secreting

ABSTRACT A patient is described in whom an ACTH-producing bronchial carcinoid tumour was found eighteen months after bilateral adrenalectomy for Cushing's syndrome. A critical review is given of laboratory methods used in the differential diagnosis of ectopic Cushing's syndrome. Finally a course of action is suggested by which such unnecessary ablative surgery might be avoided.

Failure of Somatostatin Analogue Sms 201–995 to Control Cushing's Syndrome Due to Ectopic Release of Acth from a Bronchial Carcinoid

1989 ◽  
Vol 34 (5) ◽  
pp. 533-534 ◽  
Author(s):  
L. Burrell ◽  
C.E. Gray ◽  
J.A. Thomson
Keyword(s):  
Cushing’S Syndrome ◽  
Carcinoid Tumour ◽  
Cushing's Syndrome ◽  
Somatostatin Analogue ◽  
Bronchial Carcinoid ◽  
Thymic Carcinoid ◽  
Ectopic Cushing’S Syndrome

A patient with ectopic Cushing's syndrome secondary to a malignant thymic carcinoid tumour was treated with the somatostatin analogue SMS 201–995. The administration of the drug subcutaneously in increasing doses over a 34 day period failed to control the ACTH or glucocorticoid excess.

Sign in / Sign up

Export Citation Format

Share Document